News & Updates

Neurodevelopment appears to be significantly delayed at up to 4 years of age in boys who are born to mothers with gestational diabetes mellitus (GDM), reports a recent study.

Among patients with type 2 diabetes (T2D), the use of sodium-glucose cotransporter 2 inhibitors {SGLT2i) does not appear to increase the risk of lower-limb amputation, a recent study has found.

Individuals who are diagnosed with type 2 diabetes (T2D) at age ≤40 years have a greater risk of cardiovascular disease (CVD) and mortality than same-aged individuals without T2D or individuals diagnosed with T2D in later life, according to a study from Korea presented at EASD 2022.

Among patients with type 1 diabetes (T1D), alterations in plasma glutamate levels and free amino acid profiles are distinct than that in type 2 diabetes (T2D) patients and healthy controls, a recent study has found.

Among patients with type 2 diabetes (T2D), use of the smartphone-based app InterWalk does not improve objective measures of moderate-to-vigorous physical activity (MVPA), according to a study.

Poorly controlled glycosylated haemoglobin (HbA1c) levels appear to aggravate the risk of mortality in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD), a recent study has found. Glycaemic control is not associated with progression to end-stage kidney disease (ESKD).